GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tien Liang BioTech Co Ltd (ROCO:4127) » Definitions » Gross-Profit-to-Asset %

Tien Liang BioTech Co (ROCO:4127) Gross-Profit-to-Asset % : 31.48% (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Tien Liang BioTech Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Tien Liang BioTech Co's annualized Gross Profit for the quarter that ended in Jun. 2024 was NT$206.0 Mil. Tien Liang BioTech Co's average Total Assets over the quarter that ended in Jun. 2024 was NT$654.4 Mil. Therefore, Tien Liang BioTech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 31.48%.


Tien Liang BioTech Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Tien Liang BioTech Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tien Liang BioTech Co Gross-Profit-to-Asset % Chart

Tien Liang BioTech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.25 39.55 52.84 50.54 43.01

Tien Liang BioTech Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.05 38.48 46.36 42.50 31.48

Competitive Comparison of Tien Liang BioTech Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Tien Liang BioTech Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tien Liang BioTech Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tien Liang BioTech Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Tien Liang BioTech Co's Gross-Profit-to-Asset % falls into.



Tien Liang BioTech Co Gross-Profit-to-Asset % Calculation

Tien Liang BioTech Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=286.148/( (676.429+654.035)/ 2 )
=286.148/665.232
=43.01 %

Tien Liang BioTech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=206.012/( (656.435+652.386)/ 2 )
=206.012/654.4105
=31.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Tien Liang BioTech Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Tien Liang BioTech Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tien Liang BioTech Co Business Description

Traded in Other Exchanges
N/A
Address
Datong Road, 9F, No. 147, Sec. 1, Xizhi District, New Taipei City, TWN
Tien Liang BioTech Co Ltd develops and supplies chemicals, pharmaceutical and Chinese herbs. It offers products for the treatment of intestinal track disease, osteoporosis, eye drops, cholesterin content, angiosclerosis and hepatic diseases.

Tien Liang BioTech Co Headlines

No Headlines